Bajaj Healthcare

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
313.45
11 (3.64%)
BSENSE

Mar 20

BSE+NSE Vol: 4.26 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024

Compare Profit and Loss Results of Bajaj Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
430.00
112.00
26.05%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
430.00
112.00
26.05%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-7.00
-13.00
-185.71%
Raw Materials Consumed
307.00
146.00
161.00
110.27%
Power & Fuel Cost
22.00
27.00
-5.00
-18.52%
Employee Cost
57.00
60.00
-3.00
-5.00%
Operating Expenses
63.00
57.00
6.00
10.53%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
13.00
-7.00
-53.85%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
8.00
-2.00
-25.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
329.00
131.00
39.82%
Operating Profit (PBDIT) excl Other Income
82.00
100.00
-18.00
-18.00%
Other Income
19.00
11.00
8.00
72.73%
Operating Profit (PBDIT)
101.00
112.00
-11.00
-9.82%
Interest
27.00
14.00
13.00
92.86%
Profit before Depriciation and Tax
73.00
97.00
-24.00
-24.74%
Depreciation
27.00
23.00
4.00
17.39%
Profit Before Taxation & Exceptional Items
46.00
74.00
-28.00
-37.84%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
74.00
-28.00
-37.84%
Provision for Tax
3.00
6.00
-3.00
-50.00%
Profit After Tax
42.00
67.00
-25.00
-37.31%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
276.00
-9.00
-3.26%
Profit Available for appropriations
310.00
344.00
-34.00
-9.88%
Appropriations
310.00
344.00
-34.00
-9.88%
Equity Dividend (%)
20%
50%
-30.00
Earnings Per Share
13.29
23.18
-9.89
-42.67%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024